HansBiomed Corporation (042520) — Cash Flow Quality Index
HansBiomed Corporation (042520) has a Cash Flow Quality Index of 1.70x as of June 2024. Operating cash flow of ₩159.13 Million exceeds net income of ₩93.69 Million, indicating high earnings quality where cash backs reported profits. Explore cash efficiency ratio of HansBiomed Corporation to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
HansBiomed Corporation Cash Flow Quality Index (2012–2022)
Historical Cash Flow Quality Index for HansBiomed Corporation across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check HansBiomed Corporation investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for HansBiomed Corporation (2012–2022)
Year-by-year earnings quality comparison for HansBiomed Corporation. For live market cap and the full company financial profile, see HansBiomed Corporation market cap and net worth.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | -0.69x | ₩-4.27 Billion | ₩6.15 Billion | ▼ -188.7% |
| 2019 | 0.78x | ₩7.71 Billion | ₩9.85 Billion | ▼ -37.4% |
| 2018 | 1.25x | ₩5.20 Billion | ₩4.16 Billion | ▲ +75.0% |
| 2017 | 0.72x | ₩5.60 Billion | ₩7.83 Billion | ▲ +1179.4% |
| 2016 | -0.07x | ₩-316.10 Million | ₩4.77 Billion | ▼ -109.4% |
| 2015 | 0.71x | ₩3.47 Billion | ₩4.91 Billion | ▲ +19.8% |
| 2014 | 0.59x | ₩2.06 Billion | ₩3.50 Billion | ▼ -13.2% |
| 2013 | 0.68x | ₩2.33 Billion | ₩3.43 Billion | ▲ +14.0% |
| 2012 | 0.60x | ₩1.50 Billion | ₩2.52 Billion | — |